YOLFTbeta
GeoVax Labs Inc

GeoVax Labs Inc

GOVX · NASDAQ · Healthcare / Biotechnology

1.71USD-0.33 (-16.42%)

Price History

Full chart

Market Stats

Previous Close2.04
Open2.20
Day Range1.57 – 2.20
52-Week Range0.35 – 16.80
Volume97.71K
Market Cap3.28M
P/E (TTM)0.00
Forward P/E9.65
EPS-5.29
Dividend Yield0.00%
Beta3.65
50-Day Avg0.639
200-Day Avg1.98

About

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. David Alan Dodd
  • Employees19
  • Headquarters1955 Lake Park Drive, Smyrna, GA, United States, 30080, USA
  • Websitehttps://www.geovax.com

Leadership

  • Mr. David Alan DoddChairman, President & CEO · b. 1950
  • Dr. Mark J. Newman Ph.D.Chief Scientific Officer · b. 1955
  • Dr. Kelly T. McKee Jr., M.D., M.P.H.Chief Medical Officer · b. 1950
  • Mr. Thomas O'BrienVice President of Quality Systems & Compliance
  • Mr. Jeffrey WelchHead of Process Development & Manufacturing Operations
  • Dr. John W. Sharkey Ph.D.Vice President of Business Development · b. 1956

Financials

Income Statement

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue93.95K2.73M5.37M2.28M859.84K2.62M180.24K---852.90K237.00K2.91M3.67M5.19M4.90M2.66M2.42M882.96K428.08K828.92K1.08M963.00K1.18M1.82M385.00K81.00K03.95M2.49M
Growth (%)-+2805.93%+96.61%-57.54%-62.27%+204.73%-93.12%-----72.21%+1127.90%+26.05%+41.36%-5.50%-45.77%-9.01%-63.48%-51.52%+93.64%+29.72%-10.44%+22.11%+55.03%-78.88%-78.96%-100.00%--37.06%
Cost of Revenue279.23K4.35M5.76M4.83M2.88M2.75M----1.46M4.35M6.65M6.89M7.84M7.14M4.70M2.91M1.81M1.69M1.97M2.02M1.88M1.91M2.44M15.55M56.28K20.72M95.37K18.12M
Gross Profit-185.28K-1.62M-390.38K-2.55M-2.02M-124.79K180.24K---852.90K237.00K2.91M3.67M5.19M4.90M2.66M-497.33K-930.01K-1.27M-1.14M-942.08K-915.65K1.18M1.82M385.00K81.00K-20.72M3.86M-15.63M
Gross Margin-197.22%-59.17%-7.27%-112.09%-234.44%-4.76%100.00%---100.00%100.00%100.00%100.00%100.00%100.00%100.00%-20.57%-105.33%-295.51%-137.76%-87.61%-95.08%100.00%100.00%100.00%100.00%-97.59%-628.02%
Operating Expense1.08M2.31M4.85M4.68M5.51M13.08M0---1.51M4.54M6.71M6.98M7.96M7.25M4.80M1.79M1.81M1.43M2.13M1.23M1.65M3.55M4.64M19.13M14.11M6.02M29.00M6.01M
Operating Income-1.27M-3.93M-5.24M-7.24M-7.53M-13.20M180.24K-676.64K-1.55M-875.81K-656.29K-4.30M-3.80M-3.32M-2.77M-2.35M-2.14M-2.29M-2.74M-2.69M-3.27M-2.17M-2.56M-2.37M-2.82M-18.75M-14.03M-26.74M-25.14M-21.64M
Operating Margin-1351.09%-143.88%-97.62%-317.58%-875.82%-503.93%100.00%----76.95%-1816.13%-130.62%-90.38%-53.44%-47.94%-80.50%-94.70%-310.05%-629.50%-394.90%-202.22%-266.15%-201.76%-154.53%-4869.09%-17319.75%--635.83%-869.34%
EBITDA-1.24M-3.83M-4.92M-6.14M-6.70M-11.57M180.24K-653.85K-1.60M-1.35M-607.20K-4.25M-3.74M-3.19M-2.63M-2.24M-2.05M-2.21M-2.67M-2.67M-3.24M-2.14M-2.54M-2.36M-2.80M-18.71M-13.97M-25.89M-24.88M-21.40M
EBITDA Margin-1315.47%-140.45%-91.69%-269.25%-779.59%-441.70%100.00%----71.19%-1793.15%-128.53%-87.09%-50.67%-45.67%-76.98%-91.44%-302.23%-622.74%-391.22%-199.22%-264.09%-200.51%-153.45%-4859.09%-17250.27%--629.03%-859.57%
Net Income36.67M-3.99M-6.13M-9.31M-8.82M-13.25M-618.14K-3.08M-2.21M-1.41M-584.17K-4.24M-3.73M-3.28M-2.75M-2.35M-2.13M-2.28M-2.73M-2.69M-3.27M-2.17M-2.56M-2.37M-2.94M-18.53M-14.01M-25.97M-24.99M-21.46M
Net Income Margin39031.23%-146.08%-114.23%-408.34%-1025.47%-505.78%-342.96%----68.49%-1789.76%-128.11%-89.53%-52.98%-47.90%-80.35%-94.51%-309.59%-628.22%-394.70%-201.82%-265.84%-201.60%-161.18%-4813.37%-17301.93%--631.98%-862.34%
R&D76.71K827.84K1.58M510.29K1.47M2.43M----665.86K1.76M3.74M4.07M4.79M4.28M3.04M2.91M1.81M1.69M1.97M2.02M1.88M1.91M2.44M15.55M9.12M20.72M23.71M18.12M
R&D as % of Total Revenue81.65%30.32%29.37%22.39%171.21%92.89%----78.07%741.39%128.57%110.92%92.45%87.28%114.53%120.57%205.33%395.51%237.76%187.61%195.12%162.49%134.06%4040.00%11262.96%-599.65%728.02%
Interest Expense2.31K0968.41K01.37M274.41K0554.89K337.24K62.13K0000000000002.59K4.50K143.52K1.29K56.84K021.38K0
Interest Expense % of Total Revenue2.46%0.00%18.04%0.00%159.35%10.47%0.00%---0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.27%0.38%7.87%0.33%70.18%-0.54%0.00%

Balance Sheet

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.40M7.27M6.72M3.37M11.16M3.92M371.03K172.20K19.16K78.38K2.40M3.25M3.06M4.32M2.36M1.65M1.48M2.84M1.33M1.33M610.22K490.24K642.00K468.88K10.39M11.80M31.35M9.28M8.16M6.34M
Total Liabilities309.96K1.59M3.83M2.82M639.91K1.87M1.01M3.99M4.97M5.79M193.11K598.54K346.42K571.37K521.61K941.53K327.04K312.35K187.02K126.99K369.85K811.29K1.66M2.04M825.00K7.43M4.75M3.52M3.11M2.52M
Total Equity3.09M5.68M2.89M552.34K10.52M2.05M-639.39K-3.82M-4.95M-5.72M2.20M2.65M2.71M3.74M1.84M703.61K1.15M2.53M1.15M1.20M240.37K-321.06K-1.02M-1.57M9.57M4.36M26.60M5.76M5.05M3.83M
Cash388.60K3.62M55.70K31.09K2.68M725.36K-3267.83K78.38K2.09M1.99M2.19M3.52M1.08M1.17M1.04M2.51M1.10M1.06M454.03K312.73K260.00K283.34K9.88M11.42M27.61M6.45M5.51M3.09M
Total Debt43.20K516.92K1.52M898.43K269.01K1.28M-1.31M3.57M4.04M-----677.33K129.37K60.00K78.92K---300.00K39.74K198.06K----843.17K
Net Debt-345.40K-3.10M1.46M867.34K-2.41M553.92K-1.31M3.56M3.97M-2.09M-1.99M-2.19M-3.52M-1.08M-490.65K-906.55K-2.45M-1.02M-1.06M-454.03K-312.73K40.00K-243.60K-9.69M-11.42M-27.61M-6.45M-5.51M-2.24M

Cash Flow

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.17M-2.45M-5.35M-4.46M-6.33M-4.21M288.31K-1.23M-1.43M-1.33M-3.27M-2.37M-1.43M-2.01M-303.62K-2.44M-1.69M-2.25M-2.71M-1.95M-1.69M-1.54M-1.40M-2.75M-11.20M-19.03M-25.17M-24.68M-21.47M
Investing Cash Flow-81.21K-201.97K-1.37M-15.68K-6.03M-661.28K7.67K---69.47K--99.83K-270.25K874-11.90K--86.60K-35.50K-15.85K-15.85M-4.35K-7.61K-7.61K-156.79K-47.72K-134.26K-48.95K-20.65K-27.61K
Financing Cash Flow1.77M5.65M3.15M4.45M15.01M2.92M-393.11K1.24M1.50M2.21M3.17M2.67M3.02M-430.40K404.41K2.31M3.26M873.40K2.68M1.34M1.55M1.49M1.43M12.51M12.78M35.35M4.06M23.75M19.08M
Capital Expenditure81.21K201.97K1.07M25.68K2.19K661.28K00069.47K099.83K270.25K4.71K11.90K086.60K35.50K15.85K15.85M4.35K7.61K7.60K156.79K47.72K134.26K48.95K20.65K27.61K
Free Cash Flow-1.25M-2.65M-6.42M-4.48M-6.33M-4.87M288.31K-1.23M-1.43M-1.40M-3.27M-2.47M-1.70M-2.01M-315.52K-2.44M-1.78M-2.29M-2.72M-17.80M-1.69M-1.54M-1.41M-2.91M-11.24M-19.16M-25.22M-24.70M-21.50M
FCF to OCF106.97%108.25%119.97%100.58%100.03%115.70%100.00%100.00%100.00%105.23%100.00%104.22%118.96%100.23%103.92%100.00%105.11%101.58%100.59%914.44%100.26%100.00%100.54%105.70%100.43%100.71%100.19%100.08%100.13%

Earnings

Report DateMar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011May 30, 2012Aug 29, 2012Nov 14, 2012Mar 11, 2013May 2, 2013Aug 12, 2013Nov 12, 2013Mar 5, 2014May 2, 2014Aug 8, 2014Nov 12, 2014Mar 20, 2015May 13, 2015Aug 4, 2015Nov 12, 2015Mar 16, 2016May 4, 2016Aug 5, 2016Nov 14, 2016Mar 24, 2017May 8, 2017Aug 7, 2017Nov 9, 2017Mar 23, 2018May 3, 2018Aug 7, 2018Nov 8, 2018Mar 26, 2019May 13, 2019Aug 13, 2019Nov 7, 2019Mar 24, 2020May 5, 2020Aug 10, 2020Nov 5, 2020Mar 23, 2021May 6, 2021Aug 11, 2021Nov 11, 2021Mar 9, 2022Apr 27, 2022Aug 3, 2022Nov 9, 2022Mar 23, 2023May 4, 2023Aug 9, 2023Nov 8, 2023Feb 29, 2024May 14, 2024Aug 6, 2024Nov 12, 2024Feb 26, 2025May 1, 2025Jul 28, 2025Nov 13, 2025Dec 31, 2025May 14, 2026Jul 27, 2026Nov 12, 2026
EPS Estimate--------------------------------------600000.00-1000000.00-1000000.00-1000000.00-1000000.00--1000000.00-1000000.00-1000000.00--1000000.00-1000000.00-1000000.00-1000000.00--1000000.00-1000000.00-1000000.00--1000000.00-1000000.00-1000000.00------1000000.00-1000000.00-1040.00-0.13-0.03-0.73-15.00-0.29-161.25-138.75-0.40-116.25-112.50-45.00-0.20-84.37-63.75-90.00-105.00-5.56-84.12-32.90-0.77-16.44-9.00-6.62-5.35-0.84-2.16-1.02
EPS Actual-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.001000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-400000.00-600000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-600000.00-1000000.00-1000000.00-1000000.00-1000000.00-749302.88-1000000.00-1000000.00-1000000.00-0.01-1000000.00-1000000.00-200000.00-200000.00-2.05-1.99-1000000.00-57200.00-1000000.00-449999.77-2.52-0.13-0.03-0.73266.25-0.29-78.75-116.25-2.23-127.50-67.50-63.75-0.20-56.25-82.50-120.00-98.50-2.47-49.75-22.75-0.30-11.25-8.75-7.75--2.62-0.97-
Surprise-------------------------------------33.33%40.00%0.00%0.00%0.00%-0.00%0.00%0.00%-0.00%0.00%0.00%0.00%-0.00%0.00%0.00%-0.00%0.00%80.00%-----0.00%55.00%99.76%0.00%0.00%0.00%1875.00%0.00%51.16%16.22%-457.50%-9.68%40.00%-41.67%0.00%33.33%-29.41%-33.33%6.19%55.58%40.86%30.85%60.94%31.57%2.78%-17.07%--211.90%55.09%-
Timing---------------------------------------Pre-marketAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hours--

Key Statistics & Ratios

Market Cap3.28M
Enterprise Value15.07M
Trailing P/E0.00
Forward P/E9.65
PEG Ratio0.00
Price / Sales4.44
Price / Book5.84
EPS-5.29
Book Value0.239
Revenue (TTM)0
Gross Profit (TTM)-15.05M
EBITDA-20.47M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-891.59%
Return on Assets-256.80%
Shares Outstanding9.09M
Shares Float6.92M
Beta3.65
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 10.00
  • Strong Buy
    3
  • Buy
    1

Ownership Breakdown

Institutions
9.77%
Insiders
0.03%
Retail / Other
90.20%

Top Institutional Holders

  • Armistice Capital, LLC
    269.25K2.96%
  • Geode Capital Management, LLC
    36.08K0.40%
  • Virtu Financial LLC
    10.48K0.12%
  • Vanguard Fiduciary Trust Co
    5.07K0.06%
  • UBS Group AG
    4.25K0.05%
  • Tower Research Capital LLC
    3.53K0.04%
  • Vanguard Capital Management, LLC
    3.22K0.04%
  • BlackRock Inc
    1.09K0.01%
  • SBI Securities Co Ltd
    3840.00%
  • Wells Fargo & Co
    310.00%
  • Morgan Stanley - Brokerage Accounts
    60.00%
  • Mercer Global Advisors Inc.
    60.00%
  • Danske Bank A/S.
    30.00%
  • Caitong International Asset Management Co., Limited.
    20.00%
  • FMR Inc
    10.00%
  • State Street Corp
    00.00%
  • Moneta Group Investment Advisors Inc
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    19.31K1.11%
  • Fidelity Series Total Market Index
    8560.05%
  • Fidelity Total Market Index
    5760.03%

Stock Splits

  • Jan 12, 20261:25
  • Jan 31, 20241:15